0.6420
-0.0172
(-2.61%)
At close: April 9 at 4:00:00 PM EDT
0.6408
-0.00
(-0.19%)
After hours: April 9 at 7:40:07 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 1.31M | 2.01M | 6.64M | 8.63M |
| Low Estimate | 1.31M | 2.01M | 6.64M | 8.63M |
| High Estimate | 1.31M | 2.01M | 6.64M | 8.63M |
| Year Ago Sales | 252.1k | -- | 5.63M | 6.64M |
| Sales Growth (year/est) | 421.62% | -- | 18.06% | 30.00% |
Earnings History
| Currency in USD | 12/31/2023 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|
| EPS Est. | -0.07 | -0.06 | -0.07 |
| EPS Actual | -0.05 | -0.06 | -0.05 |
| Difference | 0.02 | 0 | 0.02 |
| Surprise % | 28.57% | 0.00% | 28.57% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MLEC | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Initiated | Maxim Group: Buy | 1/30/2024 |
Related Tickers
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.2930
-1.35%
FLUI.ST Fluicell AB (publ)
12.42
+7.25%
2GH.BE Merus NV
35.80
-0.56%
SIMRIS-B.ST Simris Group AB (PUBL)
0.0968
-0.41%
22Z.SG Zealand Pharma A/S
61.14
+8.98%
5KW.F SkinBioTherapeutics plc
0.2000
0.00%
DBP-B.ST Double Bond Pharmaceutical Int.
0.2710
-3.90%
HPHA.F Heidelberg Pharma AG
2.6200
+0.77%
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
CHOSA.ST CHOSA Oncology AB
0.6500
-18.75%